OptimizeRx (OPRX) Total Current Liabilities (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Total Current Liabilities data on file, last reported at $10.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 43.01% year-over-year to $10.5 million; the trailing twelve-month figure through Mar 2026 stood at $10.5 million (down 43.01% YoY), and the FY2025 full-year result was $21.3 million, up 13.99% from the prior year.
• Total Current Liabilities slipped to $10.5 million in Q1 2026, from $21.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $21.3 million in Q4 2025 to a low of $5.5 million in Q2 2023.
• A 5-year average of $13.0 million and a median of $14.5 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 171.45% in 2024 and plunged 43.01% in 2026, its largest moves.
• Tracing OPRX's Total Current Liabilities over 5 years: stood at $8.4 million in 2022, then soared by 112.99% to $17.9 million in 2023, then gained by 4.32% to $18.7 million in 2024, then increased by 13.99% to $21.3 million in 2025, then plunged by 50.81% to $10.5 million in 2026.
• Business Quant data shows OPRX's Total Current Liabilities at $10.5 million in Q1 2026, $21.3 million in Q4 2025, and $18.5 million in Q3 2025.